As of 2024-12-14, the Intrinsic Value of IRadimed Corp (IRMD) is
61.00 USD. This IRMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 52.63 USD, the upside of IRadimed Corp is
15.90%.
The range of the Intrinsic Value is 41.08 - 135.87 USD
61.00 USD
Intrinsic Value
IRMD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
41.08 - 135.87 |
61.00 |
15.9% |
| DCF (Growth 10y) |
60.14 - 196.45 |
88.91 |
68.9% |
| DCF (EBITDA 5y) |
65.88 - 75.69 |
70.05 |
33.1% |
| DCF (EBITDA 10y) |
85.61 - 104.83 |
93.99 |
78.6% |
| Fair Value |
36.75 - 36.75 |
36.75 |
-30.17% |
| P/E |
54.40 - 61.69 |
57.18 |
8.6% |
| EV/EBITDA |
45.40 - 52.98 |
48.89 |
-7.1% |
| EPV |
15.18 - 18.55 |
16.87 |
-67.9% |
| DDM - Stable |
11.65 - 44.30 |
27.98 |
-46.8% |
| DDM - Multi |
23.80 - 67.23 |
34.80 |
-33.9% |
IRMD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
666.82 |
| Beta |
1.30 |
| Outstanding shares (mil) |
12.67 |
| Enterprise Value (mil) |
615.10 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.41% |
| Cost of Debt |
5.00% |
| WACC |
6.76% |